Acute cholestatic hepatitis induced by fenofibrate

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 5, 2009, Pages 599-602

  Hajdu, D ^a   Aiglova K ^a   Vinklerova I ^a   Urbanek K ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Adverse effects; Anticholesteremic agents; Cholestatic hepatitis; Fenofibrate; Liver diseases

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FENOFIBRATE; GAMMA GLUTAMYLTRANSFERASE; PREDNISONE; URSODEOXYCHOLIC ACID;

ACUTE HEPATITIS; ADULT; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; INTRAHEPATIC BILE DUCT; LABORATORY TEST; LIVER CELL DAMAGE; LIVER TOXICITY; PATIENT COMPLIANCE; TREATMENT OUTCOME;

ACUTE DISEASE; ANTILIPEMIC AGENTS; CHOLESTASIS, INTRAHEPATIC; FEMALE; HEPATITIS, TOXIC; HUMANS; MIDDLE AGED; PROCETOFEN;

EID: 70049115131     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01029.x     Document Type: Article

References (19)

1. Keating GM, Croom KF (2007) Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus. Drugs, 67, 121 153.
2. Guay DR (1999) Micronized fenofibrate: a new fibric acid hypolipidemic agent. The Annals of Pharmacotherapy, 33, 1083 1103.
3. Chang CY, Schiano TD (2007) Review article: drug hepatotoxicity. Alimentary Pharmacology and Therapeutics, 25, 1135 1151.
4. Ganne-Carrie N, de Leusse A, Guettier C et al. (1998) Autoimmune hepatitis induced by fibrates. Gastroenterologie Clinique et Biologique, 22, 525 529.
5. Lepicard A, Mallat A, Zafrani ES, Dhumeaux D (1994) Chronic lesion of the interlobular bile ducts induced by fenofibrate. Gastroenerologie Clinique et Biologique, 18, 1033 1035.
6. Bernard PH, Lamouliatte H, Le BailB, Bioulac-Sage P, Quinton A, Balabaud C (1994) Chronic active hepatitis associated with antinuclear antibodies induced by fenofibrate. Gastroenterologie Clinique et Biologique, 18, 1048 1049.
7. Chatrenet P, Regimbeau C, Ramain JP, Peenot J, Bruandet P (1993) Chronic active cirrhogenic hepatitis induced by fenofibrate. Gastroenterologie Clinique et Biologique, 17, 612 613.
8. Rigal J, Furet Y, Autret E, Breateau M (1989) Severe mixed hepatitis caused by fenofibrate? A rewiew of the literature apropos of a case. Revue de Medecine Interne, 10, 65 67.
9. Pichon N, Vincensini JF, Rozière A, Labrousse F, Sautereau D, Pillegand B (2003) Acute cytolytic and cholestatic hepatitis induced by fenofibrate. Gastroenterologie Clinique et Biologique, 27, 947 949.
10. Couzigou P, Boutiller P, Boisseau C, Faucher P, De Mascarel A, Amouretti M et al. (1980) Drug-induced hepatitis due to fenofibrate. Therapie, 35, 403.
11. Massen H, Furet Y (1986) Hepatite au fenofibrate. Cahiers d'Anesthesiologie, 34, 249 250.
12. Lelouch S, Pellettier G, Sinico M, Ducreux M, Etienne JP (1992) Fenofibrate-induced acute hepatitis mimicking biliary tract disease. Gastroenterologie Clinique et Biologique, 16, 597 599.
13. Bravo ML, Azagra R, Aguye A, Freixas M (1992) Acute hepatitis: an adverse reaction to fenofibrate treatment. Atencion Primaria, 10, 697 698.
14. Rouhier ML, Rifflet H, Rifflet I, Oberti F, Vuillemin E, Chevailler A, Calès P (1996) Painful acute liver involvement related to ingestion of fenofibrate. Gastroenterologie Clinique et Biologique, 20, 1137 1138.
15. Fartoux-Heymann L, Narcy-Lambare B, Labayle D, Fischer D (2001) Acute hepatitis and drug dermatitis due to fenofibrate (Secalip). Annales de Medecine Interne (Paris), 152, 353 354.
16. Ho CY, Kuo TH, Chen TS, Tsay SH, Chang FY, Lee SD (2004) Fenofibrate-induced acute cholestatic hepatitis. Case report. Journal of the Chinese Medical Association, 67, 245 247.
17. Caroli-Bosc FX, Le Gall P, Pugliese P et al. (2000) Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population. Digestive Diseases and Sciences, 46, 540 544.
18. Dohmen K, Mizuta T, Nakamuta M, Shimohashi N, Ishibashi H, Yamamoto K (2004) Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World Journal of Gastroenterology, 10, 894 898. (Pubitemid 38418369)
19. Dohmen K, Wen CY, Nagaoka S et al. (2005) Fenofibrate-induced liver injury. World Journal of Gastroenterology, 11, 7702 7703.